Teaching Cases in Nuclear Medicine: Non-oncological Applications

This chapter is designed to clarify the role of Nuclear Medicine in the clinical decision-making process of non-oncological diseases. It presents a number of typical cases referring to one or a group of diseases. Being diverse in scope, the cases provide

  • PDF / 9,110,050 Bytes
  • 60 Pages / 595.276 x 790.866 pts Page_size
  • 34 Downloads / 154 Views

DOWNLOAD

REPORT


47

Venanzio Valenza, Isabella Bruno, Daniela Di Giuda, Germano Perotti, Fabrizio Cocciolillo, Valerio Lanni, Lucia Leccisotti, Daria Maccora, and Valentina Scolozzi

Contents 47.1.1 47.1.2 47.1.3

Case No. 1: [18F]FDG Brain PET in Mild Cognitive Impairment and Alzheimer’s Disease Presentation Findings Discussion

 1142  1142  1142  1142

47.2 47.2.1 47.2.2 47.2.3

 ase No. 2: Brain SPECT with 99mTc-HMPAO in Alzheimer’s Disease C Presentation Findings Discussion

 1143  1143  1144  1145

47.3 47.3.1 47.3.2 47.3.3

 ase No. 3: Brain PET with 18F-Florbetapir in Mild Cognitive Impairment C Presentation Findings Discussion

 1145  1145  1145  1145

47.4

Case No. 4: Brain SPECT with 99mTc-HMPAO and 123I-FP-CIT in differential Diagnosis between Alzheimer’s Disease and Dementia with Lewy Bodies Presentation Findings Discussion

 1146  1146  1146  1146

47.5.1 47.5.2 47.5.3

 ase No. 5: Brain PET with [18F]FDG and Brain SPECT with 123I-FP-CIT Dementia C with Lewy Bodies Presentation Findings Discussion

 1147  1147  1147  1150

47.6 47.6.1 47.6.2 47.6.3

 ase No. 6: Brain SPECT with 99mTc-ECD in Frontotemporal Dementia C Presentation Findings Discussion

 1150  1150  1150  1150

47.7 47.7.1 47.7.2 47.7.3

 ase No. 7: Brain SPECT with 123I-FP-CIT in Parkinson’s Disease C Presentation Findings Discussion

47.1

47.4.1 47.4.2 47.4.3 47.5

 1150    1150    1152    1152

V. Valenza (*) · D. Di Giuda · D. Maccora Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Rome, Italy Nuclear Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy e-mail: [email protected] I. Bruno · G. Perotti · F. Cocciolillo · V. Lanni L. Leccisotti · V. Scolozzi Nuclear Medicine Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy © Springer Nature Switzerland AG 2019 D. Volterrani et al. (eds.), Nuclear Medicine Textbook, https://doi.org/10.1007/978-3-319-95564-3_47

1139

1140

V. Valenza et al. 47.8 47.8.1 47.8.2 47.8.3

Case No. 8: Brain SPECT with 123I-FP-CIT in Drug-­Induced Parkinsonism Presentation Findings Discussion

 1152  1152  1153  1153

47.9 47.9.1 47.9.2 47.9.3

 ase No. 9: Brain SPECT with 123I-FP-CIT in Psychogenic Parkinsonism C Presentation Findings Discussion

 1153 1153 1154 1154

47.10 47.10.1  47.10.2  47.10.3 

Case No. 10: Brain SPECT with 123I-FP-CIT in Vascular Parkinsonism Presentation Findings Discussion

 1154 1154 1154 1155

47.11 47.11.1  47.11.2  47.11.3 

 ase No. 11: PET/CT with [13N]Ammonia in Multivessel Coronary Artery Disease C  1156 Presentation    1156 Findings    1156 Discussion  1157

 ase No. 12: PET/CT with [13N]Ammonia C and with [18F]FDG for Myocardial Viability Assessment 47.12.1  Presentation 47.12.2  Findings 47.12.3  Discussion

 1161  1161  1161  1162

 ase No. 13: Myocardial Perfusion SPECT/CT C with 99mTc-Tetrofosmin for Severe Ischemia 47.13.1  Presentation 47.13.2  Findings 47.13.3  Discussion

 1162  1162  1